Analyst Ratings for Ovid Therapeutics Inc (OVID) [Neutrals]
OVID Rating Summary
OVID Price Target Summary
- Highest: $11.00 (BTIG)
- Lowest: $4.00 (Citi)
- Average: $7.80
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.80 (+141.5%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 69%
Avg. $ Target:
$7.80 (+141.5%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 69%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/20/2021 | Cantor Fitzgerald | Charles C. Duncan | Downgrade | Neutral (Buy) |
4.00 (N/A) |
3.78 (3.23) |
-14.55% | Details |
| 3/3/2021 | RBC Capital » Updated 4/20/2021 |
Brian Abrahams | Downgrade | Sector Perform (Outperform) |
4.00 (5.00) |
2.96 (3.23) |
9.12% | Details |
 |
||||||||
|
||||||||
